| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADA
|
adenosine deaminase
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADPGK
|
ADP-dependent glucokinase
|
|
ADRB1
|
adrenoceptor beta 1
|
|
AFG3L2
|
AFG3-like AAA ATPase 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
ALDH1B1
|
aldehyde dehydrogenase 1 family, member B1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
AMD1
|
adenosylmethionine decarboxylase 1
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARG2
|
arginase 2
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN7
|
ataxin 7
|
|
AURKA
|
aurora kinase A
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AXIN2
|
axin 2
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCND1
|
cyclin D1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD1D
|
CD1d molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2A-AS1
|
CDKN2A antisense RNA 1 (head to head)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGB
|
chromogranin B
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CLDN19
|
claudin 19
|
|
CLDN5
|
claudin 5
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COX3
|
|
|
COX4I1
|
cytochrome c oxidase subunit IV isoform 1
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRH
|
corticotropin releasing hormone
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTSC
|
cathepsin C
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DHDH
|
dihydrodiol dehydrogenase (dimeric)
|
|
DMD
|
dystrophin
|
|
DNM2
|
dynamin 2
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FGA
|
fibrinogen alpha chain
|
|
FGB
|
fibrinogen beta chain
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXC2
|
forkhead box C2
|
|
FOXP3
|
forkhead box P3
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GLDC
|
glycine dehydrogenase (decarboxylating)
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXB13
|
homeobox B13
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAK2
|
Janus kinase 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDM5D
|
lysine (K)-specific demethylase 5D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCT
|
lactase
|
|
LEP
|
leptin
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LIPC
|
lipase, hepatic
|
|
LMNA
|
lamin A/C
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAOA
|
monoamine oxidase A
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEFV
|
Mediterranean fever
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP25
|
matrix metallopeptidase 25
|
|
MOBP
|
myelin-associated oligodendrocyte basic protein
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MT-TM
|
tRNA
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBEA
|
neurobeachin
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH3
|
notch 3
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NPY
|
neuropeptide Y
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRG1
|
neuregulin 1
|
|
OAZ1
|
ornithine decarboxylase antizyme 1
|
|
OAZ2
|
ornithine decarboxylase antizyme 2
|
|
OXTR
|
oxytocin receptor
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAH
|
phenylalanine hydroxylase
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PANK2
|
pantothenate kinase 2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCDH19
|
protocadherin 19
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHF6
|
PHD finger protein 6
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNLIP
|
pancreatic lipase
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POMC
|
proopiomelanocortin
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSEN1
|
presenilin 1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTX3
|
pentraxin 3, long
|
|
RAD51C
|
RAD51 paralog C
|
|
RB1
|
retinoblastoma 1
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RIC3
|
RIC3 acetylcholine receptor chaperone
|
|
RLN1
|
relaxin 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRB
|
retinoid X receptor, beta
|
|
SATB1
|
SATB homeobox 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SELPLG
|
selectin P ligand
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNORD115-1
|
small nucleolar RNA, C/D box 115-1
|
|
SPAST
|
spastin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSTR3
|
somatostatin receptor 3
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STX16
|
syntaxin 16
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBD
|
thrombomodulin
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TMC6
|
transmembrane channel-like 6
|
|
TMC8
|
transmembrane channel-like 8
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRA
|
T cell receptor alpha locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTR
|
transthyretin
|
|
UBASH3A
|
ubiquitin associated and SH3 domain containing A
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
